March 28

dww-banner-update-2018-2.jpg

IN THIS ISSUE / MARCH 28, 2018


The burden of prior authorizations: Is it really that bad?

dww032818-lead-image-892.jpg

 

The American Medical Association (AMA) has released the results of a recent survey that examined the burden of prior authorizations on physicians and patients. The study found that physicians and their staff process an average of 29.1 prior authorization requests per week, requiring an average of 14.6 hours a week to process preauthorization requests. The effects on patient care are not insignificant either, with roughly 92% of physicians indicating that the prior authorization process delays patient access to necessary care, and 78% reporting that prior authorizations can affect treatment adherence.

As prior authorizations continue to take hold in practices across the country, physicians and their staff may be looking for some relief. Read more about how to use evidence-based medicine when managing prior authorizations in Dermatology World

Related Links: 


Take the ABMS survey on MOC

The American Board of Medical Specialties (ABMS) and its 24 member boards are seeking physician input about Maintenance of Certification (MOC) to help inform the future of board certification. Click here to complete the ABMS MOC survey. The survey is part of the ABMS’s new Continuing Board Certification: Vision for the Future initiative that was developed “to vision a system of continuing board certification that is meaningful, relevant and of value, while remaining responsive to the patients, hospitals and others who expect that physician specialists are maintaining their knowledge and skills to provide quality specialty care.”


WC_June_892px.png


Help wanted: AAD Pruritus Measure Testing Project

The Academy is seeking participants in its new Pruritus Measure Testing Project. Participants will be asked to provide data on four quality measures on pruritus. There is a process and outcome pruritus measure for dermatitis and a process and outcome pruritus measure for psoriasis. Participants will collect and report patient reports of itch using a validated assessment tool. The Project will launch in the spring and a small stipend will be provided for participants. Learn more about the Academy’s Pruritus Measure Testing Project.

Pruritus has emerged as a research target in recent years. Read more about what the specialty is doing to measure and manage chronic itch in Dermatology World.

Related Links: 


FDA approves new psoriasis biologic

The U.S. Food and Drug Administration (FDA) has approved tildrakizumab-asmn (ILUMYA) as a treatment for adults with moderate-to-severe plaque psoriasis. Tildrakizumab-asmn binds to the p19 subunit of IL-23 and is injected at a dose of 100 mg every 12 weeks, after the completion of initial doses at weeks zero and four.

While biologics may be a boon for psoriasis patients, are they effective for patients with scalp psoriasis? Read more about scalp psoriasis and other conditions that can cause itchy scalp in Dermatology World.

Related Links:


March-CTC-quiz-892-web.png


Health care cyberattacks on the rise

According to the latest McAfee Labs Threats Report, the number of publicly disclosed security incidents in the health care industry increased 211% overall in 2017. The report attributed the majority of these attacks to poor security practices.

How safe is your information? Read more about how to protect yourself and your practice from a cybersecurity breach in Dermatology World. Also, check out the Academy’s Guide to HIPAA and HITECH for Dermatology Manual and learn more about the steps you need to take to protect your patient data and avoid a breach.

Related Links:


When do copayments cost more than drugs? Fairly often, study shows.

According to a recent report published in JAMA, in the United States copayments for generic drugs cost more than the actual generic drug about 28% of the time and copayments for brand-name drugs cost more than the actual drug 6% of the time. The authors of the study looked at 2013 data on patient copayments and out-of-pocket fees, as well as the amount pharmacies get paid for filling prescriptions for patients with private health insurance, and found that among 9.5 million claims for prescription drugs, 2.2 million involved overpayments.

How much does dermatologic care cost? According to recent reports, not even physicians themselves may know. Check out Dermatology World for a breakdown of provider accuracy rates regarding dermatology drug and procedure costs.

Related Links: